Lever VC

Lever VC is a venture capital firm focused on investing in the alternative protein and food technology sectors. The firm backs early-stage and growth-stage companies developing innovative solutions across the food supply chain, including plant-based proteins, crop genetics, animal health technology, fermentation-derived ingredients, and nutritional supplements. Lever VC's portfolio reflects a thesis centered on the future of protein — spanning both the upstream agricultural inputs that make alternative proteins more cost-competitive and the downstream consumer brands bringing those products to market. Portfolio companies highlighted on the firm's website include NuCicer, a crop genetics company developing non-GM chickpeas with approximately 75% more protein than conventional varieties, with the potential to cut chickpea protein costs significantly. Another portfolio company, HerdDogg, applies digital animal health analytics to reduce on-farm livestock mortality and disease through advanced data science. Birdman, a plant-based protein and nutritional supplements brand based in Guadalajara, Mexico, represents Lever VC's interest in emerging market consumer brands, having grown to $15 million in sales by 2021 before receiving external funding. Boston Bioprocess, a contract development and manufacturing organization (CDMO), supports companies producing novel food, beauty, and industrial ingredients via fermentation — a rapidly growing area within precision fermentation and synthetic biology. Lever VC positions itself at the intersection of food innovation, agricultural technology, and alternative protein, targeting companies that address inefficiencies in how protein is grown, processed, and delivered to consumers globally. The firm appears to support portfolio companies across geographies, including North America and Latin America, and across multiple stages of commercialization.